It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADMA’s FA Score shows that 2 FA rating(s) are green whileMCRI’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADMA’s TA Score shows that 4 TA indicator(s) are bullish while MCRI’s TA Score has 4 bullish TA indicator(s).
ADMA (@Biotechnology) experienced а -14.75% price change this week, while MCRI (@Casinos/Gaming) price change was +2.52% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.
The average weekly price growth across all stocks in the @Casinos/Gaming industry was +2.45%. For the same industry, the average monthly price growth was +7.49%, and the average quarterly price growth was +6.55%.
ADMA is expected to report earnings on Aug 06, 2025.
MCRI is expected to report earnings on Jul 23, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Casinos/Gaming (+2.45% weekly)Casinos/Gaming includes companies that operate casinos, gaming services, horse racing and harness racing facilities. Think Las Vegas Sands Corp., MGM Resorts International and Wynn Resorts, Ltd. In periods of strong economic growth, consumers tend to spend on discretionary/leisure activities like gambling or games; but consumption is likely to slow down when there’s economic sluggishness.
ADMA | MCRI | ADMA / MCRI | |
Capitalization | 4.24B | 1.42B | 298% |
EBITDA | 161M | 157M | 103% |
Gain YTD | 3.440 | 8.337 | 41% |
P/E Ratio | 21.12 | 17.65 | 120% |
Revenue | 459M | 501M | 92% |
Total Cash | 71.6M | 43.4M | 165% |
Total Debt | 82M | 20.4M | 402% |
ADMA | MCRI | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 75 Overvalued | 25 Undervalued | |
PROFIT vs RISK RATING 1..100 | 17 | 28 | |
SMR RATING 1..100 | 15 | 56 | |
PRICE GROWTH RATING 1..100 | 52 | 48 | |
P/E GROWTH RATING 1..100 | 100 | 18 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MCRI's Valuation (25) in the Casinos Or Gaming industry is somewhat better than the same rating for ADMA (75) in the Biotechnology industry. This means that MCRI’s stock grew somewhat faster than ADMA’s over the last 12 months.
ADMA's Profit vs Risk Rating (17) in the Biotechnology industry is in the same range as MCRI (28) in the Casinos Or Gaming industry. This means that ADMA’s stock grew similarly to MCRI’s over the last 12 months.
ADMA's SMR Rating (15) in the Biotechnology industry is somewhat better than the same rating for MCRI (56) in the Casinos Or Gaming industry. This means that ADMA’s stock grew somewhat faster than MCRI’s over the last 12 months.
MCRI's Price Growth Rating (48) in the Casinos Or Gaming industry is in the same range as ADMA (52) in the Biotechnology industry. This means that MCRI’s stock grew similarly to ADMA’s over the last 12 months.
MCRI's P/E Growth Rating (18) in the Casinos Or Gaming industry is significantly better than the same rating for ADMA (100) in the Biotechnology industry. This means that MCRI’s stock grew significantly faster than ADMA’s over the last 12 months.
ADMA | MCRI | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | 2 days ago79% |
Stochastic ODDS (%) | 2 days ago82% | 2 days ago74% |
Momentum ODDS (%) | 2 days ago80% | 2 days ago74% |
MACD ODDS (%) | 2 days ago80% | 2 days ago61% |
TrendWeek ODDS (%) | 2 days ago78% | 2 days ago68% |
TrendMonth ODDS (%) | 2 days ago76% | 2 days ago69% |
Advances ODDS (%) | 13 days ago87% | 2 days ago68% |
Declines ODDS (%) | 2 days ago75% | 9 days ago64% |
BollingerBands ODDS (%) | 2 days ago86% | N/A |
Aroon ODDS (%) | N/A | 2 days ago62% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DUST | 24.78 | 0.65 | +2.69% |
Direxion Daily Gold Miners Bear 2X ETF | |||
EFZ | 14.43 | 0.11 | +0.78% |
ProShares Short MSCI EAFE | |||
DCRE | 51.81 | 0.04 | +0.08% |
DoubleLine Commercial Real Estate ETF | |||
OUSA | 52.31 | -0.18 | -0.33% |
ALPS O'Shares US Quality Div ETF | |||
DIHP | 28.86 | -0.26 | -0.89% |
Dimensional International High Pbly ETF |
A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with IOVA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then IOVA could also see price increases.
Ticker / NAME | Correlation To ADMA | 1D Price Change % | ||
---|---|---|---|---|
ADMA | 100% | -2.15% | ||
IOVA - ADMA | 46% Loosely correlated | -2.94% | ||
TARS - ADMA | 43% Loosely correlated | -1.02% | ||
IMTX - ADMA | 41% Loosely correlated | -4.19% | ||
ACLX - ADMA | 41% Loosely correlated | -1.28% | ||
RYTM - ADMA | 40% Loosely correlated | +0.83% | ||
More |
A.I.dvisor indicates that over the last year, MCRI has been loosely correlated with BYD. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRI jumps, then BYD could also see price increases.
Ticker / NAME | Correlation To MCRI | 1D Price Change % | ||
---|---|---|---|---|
MCRI | 100% | +0.83% | ||
BYD - MCRI | 61% Loosely correlated | +0.46% | ||
GDEN - MCRI | 60% Loosely correlated | N/A | ||
RRR - MCRI | 58% Loosely correlated | -1.02% | ||
VAC - MCRI | 55% Loosely correlated | +0.54% | ||
CZR - MCRI | 54% Loosely correlated | +1.44% | ||
More |